Literature DB >> 16846453

Atopy patch test for the diagnosis of food protein-induced enterocolitis syndrome.

Matthew I Fogg1, Terri A Brown-Whitehorn, Nicholas A Pawlowski, Jonathan M Spergel.   

Abstract

Food protein-induced enterocolitis syndrome (FPIES) is thought to be a non-IgE mediated food allergy syndrome. Affected infants typically demonstrate gastrointestinal symptoms after hours after ingestion of the offending food. Traditional allergy testing is not useful for this disorder because tests for food specific IgE are routinely negative. A diagnostic oral food challenge (OFC) is the only method to confirm the diagnosis of FPIES. This prospective study was undertaken to determine whether the atopy patch test (APT) is able to predict the results of the OFC. Nineteen infants with suspected FPIES by clinical history underwent APT to the suspected foods. After APT was performed, subjects underwent OFC to determine whether FPIES was present. The results of APT and OFC were compared and used to calculate sensitivity and specificity of the APT. APT predicted the results of oral food challenges in 28/33 instances. There were 16 cases of FPIES confirmed by oral food challenges. In all 16 cases of FPIES, the APT was positive to the suspected food. However, the APT was positive in five instances where the oral food challenge was negative. All 12 patients with a negative APT had a negative oral food challenge to the suspected food. APT appears to be a promising diagnostic tool for the diagnosis of FPIES.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16846453     DOI: 10.1111/j.1399-3038.2006.00418.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  23 in total

Review 1.  Diagnosis of food allergy: epicutaneous skin tests, in vitro tests, and oral food challenge.

Authors:  Jay A Lieberman; Scott H Sicherer
Journal:  Curr Allergy Asthma Rep       Date:  2011-02       Impact factor: 4.806

Review 2.  Food-Related Contact Dermatitis, Contact Urticaria, and Atopy Patch Test with Food.

Authors:  Alexandra Walter; Marlene Seegräber; Andreas Wollenberg
Journal:  Clin Rev Allergy Immunol       Date:  2019-02       Impact factor: 8.667

Review 3.  Food Protein-Induced Enterocolitis Syndrome, Allergic Proctocolitis, and Enteropathy.

Authors:  Elizabeth Feuille; Anna Nowak-Węgrzyn
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

Review 4.  Food protein-induced enterocolitis syndrome and allergic proctocolitis.

Authors:  Anna Nowak-Węgrzyn
Journal:  Allergy Asthma Proc       Date:  2015 May-Jun       Impact factor: 2.587

Review 5.  Food Protein-Induced Enterocolitis Syndrome: a Comprehensive Review.

Authors:  Amanda Agyemang; Anna Nowak-Wegrzyn
Journal:  Clin Rev Allergy Immunol       Date:  2019-10       Impact factor: 8.667

Review 6.  Milk and soy allergy.

Authors:  Jacob D Kattan; Renata R Cocco; Kirsi M Järvinen
Journal:  Pediatr Clin North Am       Date:  2011-04       Impact factor: 3.278

7.  Friend or foe? Figuring out the difference between FPIES, IgE-mediated allergy and food intolerance.

Authors:  Michelle Halbrich; Moshe Ben-Shoshan; Gregory Rex
Journal:  BMJ Case Rep       Date:  2014-04-17

8.  Poor utility of atopy patch test in predicting tolerance development in food protein-induced enterocolitis syndrome.

Authors:  Kirsi M Järvinen; Jean-Christoph Caubet; Laura Sickles; Lara S Ford; Hugh A Sampson; Anna Nowak-Węgrzyn
Journal:  Ann Allergy Asthma Immunol       Date:  2012-07-25       Impact factor: 6.347

9.  A case of milk-protein-induced enterocolitis associated with enterotoxigenic E. coli and MRSA infections.

Authors:  Nemuko Omata; Yusei Ohshima; Akiko Yamada; Motoko Yasutomi; Shuko Tokuriki; Mitsufumi Mayumi
Journal:  Eur J Pediatr       Date:  2007-06-21       Impact factor: 3.183

Review 10.  The evolution of food protein-induced enterocolitis syndrome: From a diagnosis that did not exist to a condition in need of answers.

Authors:  Lisa M Bartnikas; Anna Nowak-Wegrzyn; Fallon Schultz; Wanda Phipatanakul; Theresa A Bingemann
Journal:  Ann Allergy Asthma Immunol       Date:  2021-01-12       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.